Pharmacy Market

Nanoform Management Presentation

May 24, 2022

Nanoform Management
Our proprietary nanoforming technologies and services span the full range of drug development from small-molecule nanoparticles to large-molecule biologics. 

Spotlight

Viscadia

Viscadia is the leading professional services firm focused exclusively on pharmaceutical and biotech forecasting. With decades of pharmaceutical corporate experience, we have deep expertise in forecasting, analytics, and strategy. We work with large and mid-sized pharmaceutical and biotech companies, as well as emerging specialty pharma firms.

OTHER WHITEPAPERS
news image

Navigating the Drug Development Pipeline: Expertise for Highly Potent API Product Handling

whitePaper | July 11, 2022

The expansion in the development and manufacturing of highly potent active pharmaceutical ingredients (HPAPIs) and complex active pharmaceutical ingredients (APIs) has grown tremendously as demands in healthcare to bring newer therapies to market quicker increase.

Read More
news image

Medical Afairs Transformation in Specialty Pharma

whitePaper | March 6, 2022

Pharmaceutical companies with a medical mindset and an empowered Medical Afairs function are well equipped to meet the needs and expectations of patients and society. Yet, as capacity to understand and serve those needs accelerates.

Read More
news image

Demystifying content marketing for the pharma industry

whitePaper | November 10, 2022

We know people don’t like to be sold to. And in the so-called ‘attention economy’, it is more important than ever that your business can utilise meaningful marketing and advertising practices to engage with your customers and secure their attention.

Read More
news image

Employing Singleuse Technology to Control Frozen Bulk Drug Storage

whitePaper | September 29, 2022

New biopharmaceutical drug products that alter and even save lives can be very profitable for their developers.

Read More
news image

3 Pillars to Support a Winning Product Launch

whitePaper | January 18, 2023

The lifetime success of a pharmaceutical product is determined within the first few months following a product launch. Two-thirds of all product launches underperform and the majority of launches fail due to lack.

Read More
news image

Non-Clinical Testing Considerations: Drugs vs Devices

whitePaper | November 8, 2022

While drugs and devices differ in their development, clinical trial phases and regulatory guidelines, the most important difference is that medical devices do not achieve their principal action by pharmacological means.

Read More

Spotlight

Viscadia

Viscadia is the leading professional services firm focused exclusively on pharmaceutical and biotech forecasting. With decades of pharmaceutical corporate experience, we have deep expertise in forecasting, analytics, and strategy. We work with large and mid-sized pharmaceutical and biotech companies, as well as emerging specialty pharma firms.

Events